Trade Mark Journal No.2025/051 19 December 2025

UK00004306298 5 December 2025 (5)

SK5

International priority date claimed: 19 August 2025 (United States of America) (99/345,538)

Class 5: Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington’s Disease.

Skyhawk Therapeutics, Inc.

Representative: Appleyard Lees IP LLP